RNF144 (RNF144A) Human shRNA Plasmid Kit (Locus ID 9781)
CAT#: TL309788
RNF144A - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 5,740.00
Cited in 2 publications. |
Product images
CNY 4,070.00
Specifications
Product Data | |
Product Name | RNF144 (RNF144A) Human shRNA Plasmid Kit (Locus ID 9781) |
Locus ID | 9781 |
UniProt ID | P50876 |
Synonyms | hUIP4; RNF144; UBCE7IP4 |
Vector | pGFP-C-shLenti |
Format | Lentiviral plasmids |
Kit Components | RNF144A - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector(Gene ID = 9781). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pGFP-C-shLenti Vector, TR30021, included for free. |
RefSeq | NM_014746, NM_001349181, NM_001349182, NM_001349183, NM_001349184, NM_001349185, NM_001349186, NR_146069, NM_014746.1, NM_014746.2, NM_014746.3, NM_014746.4, NM_014746.5, BC050373, BC050373.1, BC035051, BM550396, BM931543 |
Summary | This gene encodes a member of a family of RING finger domain-containing E3 ubiquitin ligases that also includes parkin and parc. The expression of this gene is induced by DNA damage. The encoded protein interacts with the cytoplasmic DNA-dependent protein kinase, catalytic subunit (DNA-PKcs) and promotes its degradation through ubiquitination. The orthologous mouse protein has been shown to interact with a ubiquitin-conjugating enzyme involved in embryonic development. [provided by RefSeq, Mar 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2
,Yang, YL;Zhang, Y;Li, DD;Zhang, FL;Liu, HY;Liao, XH;Xie, HY;Lu, Q;Zhang, L;Hong, Q;Dong, WJ;Li, DQ;Shao, ZM;,
Cell Death Differ.
,PubMed ID 31406303
[RNF144A]
|
RBR-type E3 ubiquitin ligase RNF144A targets PARP1 for ubiquitin-dependent degradation and regulates PARP inhibitor sensitivity in breast cancer cells
,Zhang, Y;Liao, XH;Xie, HY;Shao, ZM;Li, DQ;,
Oncotarget
,PubMed ID 29212245
[RNF144A]
|
Documents
Product Manuals |
FAQs |
SDS |
其它RNF144A产品